| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |